Correlation Between Adaptimmune Therapeutics and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Protara Therapeutics, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Protara Therapeutics.
Diversification Opportunities for Adaptimmune Therapeutics and Protara Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Adaptimmune and Protara is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Protara Therapeutics
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to under-perform the Protara Therapeutics. In addition to that, Adaptimmune Therapeutics is 1.12 times more volatile than Protara Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about 0.26 per unit of volatility. If you would invest 183.00 in Protara Therapeutics on August 29, 2024 and sell it today you would earn a total of 111.00 from holding Protara Therapeutics or generate 60.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Protara Therapeutics
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Protara Therapeutics |
Adaptimmune Therapeutics and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Protara Therapeutics
The main advantage of trading using opposite Adaptimmune Therapeutics and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.The idea behind Adaptimmune Therapeutics Plc and Protara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |